These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8074901)

  • 1. [Control of drooling with scopolamine ointment for severely disabled].
    Yokoyama R; Kawara H; Ishii H
    No To Hattatsu; 1994 Jul; 26(4):357-8. PubMed ID: 8074901
    [No Abstract]   [Full Text] [Related]  

  • 2. Scolpolamine patch for clozapine-induced sialorrhea.
    Gaftanyuk O; Trestman RL
    Psychiatr Serv; 2004 Mar; 55(3):318. PubMed ID: 15001737
    [No Abstract]   [Full Text] [Related]  

  • 3. Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.
    Goto T; Kato M; Matsumura Y; Omata N; Yoshida M; Watanabe K; Takahashi T; Higashima M; Wada Y
    J Clin Psychopharmacol; 2017 Feb; 37(1):106-107. PubMed ID: 27846048
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
    Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H
    Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of salivary flow with Scopoderm TTS.
    Talmi YP; Finkelstein Y; Zohar Y; Laurian N
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):128-30. PubMed ID: 3355042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal scopolamine for reduction of drooling in developmentally delayed children.
    Lewis DW; Fontana C; Mehallick LK; Everett Y
    Dev Med Child Neurol; 1994 Jun; 36(6):484-6. PubMed ID: 7516297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of drooling in disabled patients with scopolamine patches.
    Mato A; Limeres J; Tomás I; Muñoz M; Abuín C; Feijoo JF; Diz P
    Br J Clin Pharmacol; 2010 Jun; 69(6):684-8. PubMed ID: 20565460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application Site of Transdermal Scopolamine Influences Efficacy and Drug Concentration in Salivary Glands in Rats.
    Ishida N; Oshima Y; Katsura A; Imamura R; Arakawa H; Shimada T; Mizuno S; Sai Y; Suga Y; Matsushita R
    Biol Pharm Bull; 2023; 46(12):1805-1809. PubMed ID: 38044099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients.
    Tassinari D; Poggi B; Fantini M; Tamburini E; Sartori S
    Support Care Cancer; 2005 Jul; 13(7):559-61. PubMed ID: 15864657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of drooling with transdermal scopolamine in a child with cerebral palsy.
    Siegel LK; Klingbeil MA
    Dev Med Child Neurol; 1991 Nov; 33(11):1013-4. PubMed ID: 1743423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of transdermal scopolamine to control drooling. A case report.
    Dreyfuss P; Vogel D; Walsh N
    Am J Phys Med Rehabil; 1991 Aug; 70(4):220-2. PubMed ID: 1878183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esotropia in a child treated with a scopolamine patch for drooling.
    Good WV; Crain LS
    Pediatrics; 1996 Jan; 97(1):126-7. PubMed ID: 8545207
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of salivary flow with transdermal scopolamine: a four-year experience.
    Talmi YP; Finkelstein Y; Zohar Y
    Otolaryngol Head Neck Surg; 1990 Oct; 103(4):615-8. PubMed ID: 2123321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of drooling using transdermal scopolamine skin patches. A case report.
    Mato Montero A; Limeres Posse J; Tomás Carmona I; Fernández Feijoo J; Diz Dios P
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E27-30. PubMed ID: 18167476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal scopolamine in drooling.
    Brodtkorb E; Wyzocka-Bakowska MM; Lillevold PE; Sandvik L; Saunte C; Hestnes A
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():233-7. PubMed ID: 3047394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
    Chowdhury NA; Sewatsky ML; Kim H
    Am J Phys Med Rehabil; 2017 Aug; 96(8):e151-e154. PubMed ID: 28081025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.
    van der Burg JJ; Jongerius PH; van Limbeek J; van Hulst K; Rotteveel JJ
    Eur J Pediatr; 2006 Jan; 165(1):37-41. PubMed ID: 16172877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialorrhea - therapeutic drug options.
    Tscheng DZ
    Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drooling in neuropediatric patients].
    Steffen A; Ortfeld S; Schönweiler R
    Klin Padiatr; 2011 Jan; 223(1):5-9. PubMed ID: 21271513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.